Journal Report

Journal of viral hepatitis

Download PDF
Journal Information
Journal Title
Journal of viral hepatitis
Publisher
ISSN
1352-0504
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Correction to ‘Geospatial Discrepancy of Chronic Hepatitis B and Hepatitis D Testing in Alberta: A Population‐Based Spatial Analysis’
2026-11-7 Vol. 33 Issue 12
Hepatitis B and D: Interferon‐Based Therapy—For Clinical Trials or Standard of Care—Back to the Future?
Zillah Cargill, Harry L. A. Janssen, Tarik Asselah et al.
2026-11-3 Vol. 33 Issue 12
Anti‐Viral Treatment Eligibility and Treatment Uptake Among People With Chronic Hepatitis B in Australia: The <scp>REACH</scp> ‐B Study
Behzad Hajarizadeh, Renjy Nelson, Jacob George et al.
2026-11-2 Vol. 33 Issue 12
Chronic Hepatitis B in the United States: Current Landscape, Unmet Needs and Future Directions
Chari Cohen, James Philip Esteban, Shravani Bobde et al.
2026-11-2 Vol. 33 Issue 12
Clinical Significance of Indeterminate Antibody to Hepatitis C in Cancer Patients
Joanne Arvelaez Pascucci, Khalis Mustafayev, Ying Jiang et al.
2026-10-31 Vol. 33 Issue 12
Associations Between Self‐Reported Previous Hepatitis C Diagnosis, Hepatitis C Treatment, and Current Binge Drinking Among Persons Who Inject Drugs—National <scp>HIV</scp> Behavioural Surveillance, 2015–2024
Jonathan Feelemyer, Rebecca Hershow, Jacklynn De Leon et al.
2026-10-31 Vol. 33 Issue 12
From Detecting Lesions to Delivering Care: Point‐of‐Care Ultrasound in Hepatitis B
Manti Debnath, Rajesh Prasad Jayaswal
2026-10-28 Vol. 33 Issue 12
Real‐World Effectiveness and Safety of Sofosbuvir‐Based Therapy in Chinese Children and Adolescents With Chronic <scp>HCV</scp> Infection: A Retrospective Multicentre Study
Li Liu, Mei Li, Shishu Zhu et al.
2026-10-28 Vol. 33 Issue 12
Issue Information
2026-10-28 Vol. 33 Issue 12
A Randomized, Double‐Blind, Placebo‐Controlled Study of the PD‐1 Inhibitor Cetrelimab in Chronic Hepatitis B
Tarik Asselah, Thomas N. Kakuda, Sarah Kulke et al.
2026-10-26 Vol. 33 Issue 11
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 9, 2026 05:44